SARS-CoV-2 & Flu A/B
RNA STAR Complete

Test Benefits

The LumiraDx SARS-CoV-2 & Flu A/B RNA STAR Complete multiplex assay is intended for the rapid qualitative detection and differentiation of nucleic acid from the SARS-CoV-2, Influenza A, and/or Influenza B viruses in nasopharyngeal or anterior nasal swab from individuals suspected of COVID-19 and/or influenza by their healthcare provider

  • Reliable and robust performance when compared to traditional RT-PCR tests.
  • Direct amplification within 20 minutes drives lab’s efficiency and productivity.

Test Workflows

SARS-CoV-2 & Flu A/B RNA STAR Complete - Test Workflows

Test Performance

SARS-CoV-2 & Flu A/B RNA STAR Complete - Test Performance

Not all products are available in all countries and regions. Please check with your local LumiraDx sales representative or distributor for availability in specific markets.


Supporting healthier lives, for individuals, communities and wider society.

Enabling responsive, personal relationships between patients and care teams.

Controlling and reducing costs to help ease pressure on healthcare budgets.

Be Informed